| 000 | 01693 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514234544.0 | ||
| 264 | 0 | _c20051207 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a1061-186X | ||
| 024 | 7 |
_a10.1080/10611860500207060 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFu, Guo-Hui | |
| 245 | 0 | 0 |
_aAs2O3 enhances the anion transport activity of band 3 and the action is related with the C-terminal 16 residues of the protein. _h[electronic resource] |
| 260 |
_bJournal of drug targeting _cMay 2005 |
||
| 300 |
_a235-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnion Exchange Protein 1, Erythrocyte _xgenetics |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aArsenic Trioxide |
| 650 | 0 | 4 |
_aArsenicals _xpharmacology |
| 650 | 0 | 4 |
_aErythrocytes _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLeukemia, Promyelocytic, Acute _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOxides _xpharmacology |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aYeasts _xgenetics |
| 700 | 1 | _aWang, Yong | |
| 700 | 1 | _aXi, Yu-Hui | |
| 700 | 1 | _aGuo, Zhuo-Wei | |
| 700 | 1 | _aLiu, Xiao-Bin | |
| 700 | 1 | _aBai, Shu-Zhi | |
| 700 | 1 | _aYang, Bao-Feng | |
| 700 | 1 | _aChen, Guo-Qiang | |
| 773 | 0 |
_tJournal of drug targeting _gvol. 13 _gno. 4 _gp. 235-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10611860500207060 _zAvailable from publisher's website |
| 999 |
_c15704932 _d15704932 |
||